July 21- Theranos Inc hired two executives to oversee regulatory, quality and compliance standards, in a bid to turn around the struggling blood-testing company after it received sanctions from U.S. regulators. He will work on getting FDA clearances and approvals, marketing new products, and look into medical-device quality systems. The company, once valued at... » Read More
The recent criticism surrounding $9 billion diagnostics firm Theranos has been unfair, Theranos board member Richard Kovacevich tells CNBC.
China's capital Beijing issued its second smog red alert of the month on Friday, triggering vehicle restrictions and forcing schools to close.
Rising demand for IVF in China will strain already-crowded state-run hospitals but create opportunities for overseas health centers.
Theranos only uses its finger-prick technology in one test after pressure from regulators, The WSJ reports.
As baby boomers age, UPS, FedEx and DHL expect health-care logistics to become a more important part of their future.
Teen creates cheaper way to test for Ebola
Reckitt Benckiser, the maker of Durex condoms, is calling on India to axe price controls on its products, the FT reports.
These wearables can read your mind and mood. Companies like Interaxon, Thync and Scanadu are leveraging EEG sensors to help users control their thoughts.
Mount Sinai's CEO sees a "death spiral" could occur if the Supreme Court rules against the health insurance subsidies in Obamacare.
Bad news has been a boon for Malaysia's rubber glove makers, with the ringgit's drop and South Korea's MERS outbreak likely to provide a twin boost.
The health-care sector is hot, and investors don't have to bet on the riskiest biotech stocks to profit.
John Hancock aims to use wearables to track policyholders' activity, using the information to provide differential pricing on insurance policies.
CNBC Crowdfinance Tech Index lists the largest capital commitments raised by 25 private U.S. tech companies on Crowdnetic’s data platform.
Dan Mahony, fund manager at Polar Capital, tells CNBC how to be a "smart healthcare investor".
George Freeman MP, minister of life sciences in the U.K., says there's been a "resurgence" for life sciences and healthcare investment.
How much would it cost world governments to insulate their economies from global pandemics. Would you believe nearly $344 billion?
A flu shot that lasts 10 years could be a reality soon, a top hospital executive told CNBC, along with "real steps" toward a cancer vaccine.
Analysts are expecting a jump in earnings growth from the healthcare sector, but will its success continue into 2015? Andrew Burkly, managing director and head of institutional portfolio strategy at Oppenheimer Asset Management, shares his thoughts.
Despite the endless controversies dogging Obamacare, the CEO of Mount Sinai believes the legislation is meeting many of its goals.
The first trial of an Ebola vaccine has started with the vaccination of three health care workers in Mali, researchers told NBC News.